Zalcitabine (ID: DG00888) Resistance Data of HIV
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Aberration of the Drug's Therapeutic Target (ADTT) Click to Show/Hide
Key Molecule: Gag-Pol polyprotein (POL)
Resistant Disease Human immunodeficiency virus infection [ICD-11: 1C62.0]
Molecule Alteration
Alteration Patterns Alteration Types Resistance Mutation Total Point Scores Levels of Drug resistance base on the total point score Ref
N.A.
Mutation N.A. Resistance [1]
Resistant Drug Zalcitabine
Experimental Note Identified from the Human Clinical Data
Mechanism Description Resistance to zalcitabine usually arises from a series of mutations within the HIV pol gene and develops less frequently than resistance to zidovudine.
References
Ref 1 Zalcitabine. An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection .Drugs. 1997 Jun;53(6):1054-80. doi: 10.2165/00003495-199753060-00009. 10.2165/00003495-199753060-00009

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.